| abstract |
The present invention provides an IFN-γ and / or IL-17 production inhibitor containing a cinnamic acid derivative as an active ingredient, and a Th1 cell and / or Th17 cell differentiation inhibitor. Furthermore, a pharmaceutical composition for treating and / or preventing an inflammatory disease or autoimmune disease comprising a cinnamic acid derivative as an active ingredient is provided. Inhibition of IFN-γ and / or IL-17 production comprising, as an active ingredient, at least one cinnamic acid derivative selected from the group consisting of artepilin C, dolpane, buccalin, cryforin, and caffeic acid Agent, Th1 cell and / or Th17 cell differentiation inhibitor, and pharmaceutical composition for treatment and / or prevention of inflammatory disease or autoimmune disease. [Selection figure] None |